Literature DB >> 8923055

The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine.

R Wallich1, M D Kramer, M M Simon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923055     DOI: 10.1007/bf01716093

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  10 in total

1.  Cloning and sequencing of the gene encoding the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate.

Authors:  R Wallich; U E Schaible; M M Simon; A Heiberger; M D Kramer
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

2.  Demonstration of antigen-specific T cells and histopathological alterations in mice experimentally inoculated with Borrelia burgdorferi.

Authors:  U E Schaible; M D Kramer; C W Justus; C Museteanu; M M Simon
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 4.  The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.

Authors:  M D Kramer; R Wallich; M M Simon
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 5.  A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.

Authors:  M M Simon; U E Schaible; R Wallich; M D Kramer
Journal:  Immunol Today       Date:  1991-01

Review 6.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

7.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Myositis in mice inoculated with Borrelia burgdorferi.

Authors:  C Museteanu; U E Schaible; T Stehle; M D Kramer; M M Simon
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

9.  Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.

Authors:  M M Simon; U E Schaible; M D Kramer; C Eckerskorn; C Museteanu; H K Müller-Hermelink; R Wallich
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

10.  The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.

Authors:  U E Schaible; M D Kramer; C Museteanu; G Zimmer; H Mossmann; M M Simon
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

  10 in total
  4 in total

1.  Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.

Authors:  Mark R Scheckelhoff; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2005-11-04       Impact factor: 3.641

2.  Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.

Authors:  Christina M Small; Dharani K Ajithdoss; Aline Rodrigues Hoffmann; Waithaka Mwangi; Maria D Esteve-Gassent
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

3.  Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.

Authors:  Heidelore Hofmann; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Andreas Krause; Sebastian Rauer; Bernhard Ruf
Journal:  Ger Med Sci       Date:  2017-09-05

4.  Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.

Authors:  Sebastian Rauer; Stephan Kastenbauer; Heidelore Hofmann; Volker Fingerle; Hans-Iko Huppertz; Klaus-Peter Hunfeld; Andreas Krause; Bernhard Ruf; Rick Dersch
Journal:  Ger Med Sci       Date:  2020-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.